Speak directly to the analyst to clarify any post sales queries you may have.
The surgical adhesives market is transforming procedural outcomes for modern healthcare systems, enabling more precise surgeries, improved healing, and streamlined operations across diverse clinical environments.
Market Snapshot: Growth Drivers and Outlook for the Surgical Adhesives Market
The surgical adhesives market grew from USD 1.75 billion in 2024 to USD 1.92 billion in 2025, and is projected to maintain a robust CAGR of 9.90% through to USD 3.74 billion by 2032. This expansion is spurred by rising adoption in minimally invasive surgeries, growing clinical preferences for advanced wound closure techniques, and expanding healthcare infrastructure worldwide. Ongoing innovation in polymer chemistry, biocompatible materials, and formulation science continues to accelerate market penetration, especially as clinicians and procurement leaders prioritize efficiency, patient safety, and cost-containment.
Scope & Segmentation: Comprehensive Coverage of Technologies, Applications, and Regions
- Product: Collagen-Based Adhesives, Cyanoacrylate Adhesives, Fibrin Sealants, Hydrocolloid Adhesives, Silicone Adhesives
- Composition: Biological Adhesives, Synthetic Adhesives
- Surgical Method: Minimally Invasive Surgery, Open Surgery
- Application: Cardiovascular Surgery, Cosmetic Surgery, General Surgery, Orthopedic Surgery
- End-User: Ambulatory Surgical Centers, Hospitals & Clinics, Specialty Care Centers
- Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland, United Arab Emirates, Saudi Arabia, Qatar, Turkey, Israel, South Africa, Nigeria, Egypt, Kenya), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan)
- Key Companies Profiled: 3M Company, Advanced Medical Solutions Group PLC, Artivion, Inc, B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson, and Company, Cardinal Health, Inc., Chemence Medical, Inc., Connexicon Medical Limited, CSL Behring AG, GEM S.r.l., GluStitch Inc., Grena Ltd., H.B. Fuller Company, Henkel AG & Co. KGaA, Integra LifeSciences Holdings Corporation, Johnson & Johnson Services, Inc., Kuraray America, Inc., Medline Industries, LP, Medtronic PLC, Meyer-Haake GmbH Medical Innovations, Mitsui Chemicals, Inc., Nordson Corporation, Sealantis Ltd., UFP Technologies Inc., Vivostat A/S
Key Takeaways: Strategic Insights for Decision-Makers
- Biocompatible adhesives are gaining traction for their ability to enhance tissue healing and minimize inflammatory responses in both routine and complex surgeries.
- Bioactive formulations and smart, stimuli-responsive adhesives are reshaping application possibilities, enabling more tailored responses during procedures and post-operative recovery.
- Segment-specific requirements—such as adhesion strength for orthopedic repairs and flexibility for cardiovascular or cosmetic uses—drive the need for product customization and modularity.
- Surgeons increasingly favor adhesives compatible with minimally invasive and robotic-assisted techniques, prompting vendors to prioritize innovations that support precise, low-profile delivery systems.
- Regional dynamics—including evolving healthcare reimbursement structures and the rise of local manufacturing hubs—continue to impact procurement strategies and partnership priorities.
- Collaboration among material scientists, device makers, and clinical leaders is central to bringing next-generation adhesives to market with improved speed, safety, and usability.
Tariff Impact: Navigating New Barriers and Building Supply Resilience
In 2025, revised tariff schedules in the United States surgical adhesives sector prompted manufacturers to diversify sourcing and invest in domestic production. This shift increased the focus on local supplier partnerships and manufacturing site distribution to reduce cost volatility and bolster supply chain robustness. Distributors and healthcare providers adopted new procurement models and consortium agreements, integrating flexible sourcing to maintain continuity of care amid shifting price structures.
Methodology & Data Sources
This report integrates desk research from peer-reviewed journals, regulatory filings, and patent records with primary interviews from surgeons, procurement leaders, and manufacturing specialists. Data triangulation and targeted validation workshops with industry veterans ensure the analysis captures practical market realities and strategic imperatives.
Surgical Adhesive Market: Why This Report Matters
- Delivers actionable insights to support procurement decisions, portfolio development, and geographic expansion within the surgical adhesives industry.
- Highlights how innovation, regulatory shifts, and new clinical practices converge to create operational value and differentiation for suppliers and healthcare providers.
Conclusion
The surgical adhesives market is evolving rapidly amid technological advances, shifting clinical needs, and complex supply chain dynamics. Senior leaders equipped with focused insights from this report are positioned to guide organizations through sector transformation and sustained growth.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
3. Executive Summary
4. Market Overview
7. Cumulative Impact of Artificial Intelligence 2025
Samples

LOADING...
Companies Mentioned
The key companies profiled in this Surgical Adhesives market report include:- 3M Company
- Advanced Medical Solutions Group PLC
- Artivion, Inc
- B. Braun Melsungen AG
- Baxter International Inc.
- Becton, Dickinson, and Company
- Cardinal Health, Inc.
- Chemence Medical, Inc.
- Connexicon Medical Limited
- CSL Behring AG
- GEM S.r.l.
- GluStitch Inc.
- Grena Ltd.
- H.B. Fuller Company
- Henkel AG & Co. KGaA
- Integra LifeSciences Holdings Corporation
- Johnson & Johnson Services, Inc.
- Kuraray America, Inc.
- Medline Industries, LP
- Medtronic PLC
- Meyer-Haake GmbH Medical Innovations
- Mitsui Chemicals, Inc.
- Nordson Corporation
- Sealantis Ltd.
- UFP Technologies Inc.
- Vivostat A/S
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 198 |
| Published | October 2025 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value ( USD | $ 1.92 Billion |
| Forecasted Market Value ( USD | $ 3.74 Billion |
| Compound Annual Growth Rate | 9.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 27 |

